Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Wise LM, Stuart GS, Real NC, Fleming SB, Mercer AA.

Adv Wound Care (New Rochelle). 2018 Aug 1;7(8):283-297. doi: 10.1089/wound.2016.0721.

2.

The Impact of a 72-hour Waiting Period on Women's Access to Abortion Care at a Hospital-Based Clinic in North Carolina.

Morse JE, Charm S, Bryant A, Ramesh S, Krashin J, Stuart GS.

N C Med J. 2018 Jul-Aug;79(4):205-209. doi: 10.18043/ncm.79.4.205.

3.

Treatment of limb wounds of horses with orf virus IL-10 and VEGF-E accelerates resolution of exuberant granulation tissue, but does not prevent its development.

Wise LM, Bodaan CJ, Stuart GS, Real NC, Lateef Z, Mercer AA, Riley CB, Theoret CL.

PLoS One. 2018 May 15;13(5):e0197223. doi: 10.1371/journal.pone.0197223. eCollection 2018.

4.

Reply.

Nguyen AT, Bhatti KZ, Stuart GS.

Am J Obstet Gynecol. 2019 May;220(5):504-505. doi: 10.1016/j.ajog.2018.04.055. Epub 2018 May 9. No abstract available.

PMID:
29752927
5.

Risk-Reducing Salpingectomy Versus Standard Tubal Sterilization: Lessons From Offering Women Options for Interval Sterilization.

Zerden ML, Castellano T, Doll KM, Stuart GS, Munoz MC, Boggess KA.

South Med J. 2018 Mar;111(3):173-177. doi: 10.14423/SMJ.0000000000000779.

6.

What Is New in Global Women's Health? (Part 2): Best Articles From the Past Year.

Stuart GS, Ramsey PS.

Obstet Gynecol. 2018 Feb;131(2):392-394. doi: 10.1097/AOG.0000000000002468.

PMID:
29324619
7.

What Is New in Global Women's Health? (Part 1): Best Articles From the Past Year.

Ramsey PS, Stuart GS.

Obstet Gynecol. 2018 Jan;131(1):158-160. doi: 10.1097/AOG.0000000000002425.

PMID:
29215528
8.

Interval Female Sterilization.

Stuart GS, Ramesh SS.

Obstet Gynecol. 2018 Jan;131(1):117-124. doi: 10.1097/AOG.0000000000002376. Review.

PMID:
29215509
9.

Medical abortion reversal: science and politics meet.

Bhatti KZ, Nguyen AT, Stuart GS.

Am J Obstet Gynecol. 2018 Mar;218(3):315.e1-315.e6. doi: 10.1016/j.ajog.2017.11.555. Epub 2017 Nov 12. Review.

PMID:
29141197
10.

Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.

Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD.

Contraception. 2018 Mar;97(3):210-214. doi: 10.1016/j.contraception.2017.10.005. Epub 2017 Oct 13.

PMID:
29038072
11.

Dual Method Use among Postpartum HIV-Infected and HIV-Uninfected Malawian Women: A Prospective Cohort Study.

Kopp DM, Tang JH, Stuart GS, Miller WC, O'Shea MS, Hosseinipour MC, Bonongwe P, Mwale M, Rosenberg NE.

Infect Dis Obstet Gynecol. 2017;2017:1475813. doi: 10.1155/2017/1475813. Epub 2017 Jul 18.

12.

Management of Intrauterine Contraception in Early Pregnancy.

Ramesh SS, Charm S, Kalinowski A, Liberty AL, Stuart GS.

South Med J. 2017 Aug;110(8):550-553. doi: 10.14423/SMJ.0000000000000685.

PMID:
28771655
13.

Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.

Krashin JW, Stuart GS, Garrett J, Spector H, Bryant AG, Charm S, Morse JE.

Obstet Gynecol. 2017 Jul;130(1):109-117. doi: 10.1097/AOG.0000000000002070.

PMID:
28594755
14.

Patterns of Contraceptive Adoption, Continuation, and Switching after Delivery among Malawian Women.

Kopp DM, Rosenberg NE, Stuart GS, Miller WC, Hosseinipour MC, Bonongwe P, Mwale M, Tang JH.

PLoS One. 2017 Jan 20;12(1):e0170284. doi: 10.1371/journal.pone.0170284. eCollection 2017.

15.

Drug interactions between hormonal contraceptives and antiretrovirals.

Nanda K, Stuart GS, Robinson J, Gray AL, Tepper NK, Gaffield ME.

AIDS. 2017 Apr 24;31(7):917-952. doi: 10.1097/QAD.0000000000001392. Review.

16.

A Broad-Spectrum Chemokine-Binding Protein of Bovine Papular Stomatitis Virus Inhibits Neutrophil and Monocyte Infiltration in Inflammatory and Wound Models of Mouse Skin.

Sharif S, Nakatani Y, Wise L, Corbett M, Real NC, Stuart GS, Lateef Z, Krause K, Mercer AA, Fleming SB.

PLoS One. 2016 Dec 9;11(12):e0168007. doi: 10.1371/journal.pone.0168007. eCollection 2016.

17.

Short-term treatment of equine wounds with orf virus IL-10 and VEGF-E dampens inflammation and promotes repair processes without accelerating closure.

Bodaan CJ, Wise LM, Wakelin KA, Stuart GS, Real NC, Mercer AA, Riley CB, Theoret C.

Wound Repair Regen. 2016 Nov;24(6):966-980. doi: 10.1111/wrr.12488. Epub 2016 Oct 18.

PMID:
27681311
18.

Etonogestrel-Releasing Contraceptive Implant for Postpartum Adolescents: A Randomized Controlled Trial.

Bryant AG, Bauer AE, Stuart GS, Levi EE, Zerden ML, Danvers A, Garrett JM.

J Pediatr Adolesc Gynecol. 2017 Jun;30(3):389-394. doi: 10.1016/j.jpag.2016.08.003. Epub 2016 Aug 22.

PMID:
27561981
19.

Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes.

Zerden ML, Stuart GS, Charm S, Bryant A, Garrett J, Morse J.

Contraception. 2017 Jan;95(1):65-70. doi: 10.1016/j.contraception.2016.08.005. Epub 2016 Aug 20.

PMID:
27554014
20.

Association between contraceptive implant knowledge and intent with implant uptake among postpartum Malawian women: a prospective cohort study.

Tang JH, Kopp DM, Stuart GS, O'Shea M, Stanley CC, Hosseinipour MC, Miller WC, Mwale M, Kaliti S, Bonongwe P, Rosenberg NE.

Contracept Reprod Med. 2016 Aug 10;1:13. doi: 10.1186/s40834-016-0026-1. eCollection 2016.

21.

Reasons for Intrauterine Device Use, Discontinuation and Non-Use in Malawi: A Qualitative Study of Women and their Partners.

Bryant AG, Hamela G, Gotter A, Stuart GS, Kamanga G.

Afr J Reprod Health. 2015 Dec;19(4):50-7.

PMID:
27337853
22.

Renewing focus on family planning service quality globally.

Hancock NL, Stuart GS, Tang JH, Chibwesha CJ, Stringer JSA, Chi BH.

Contracept Reprod Med. 2016 Jun 22;1:10. doi: 10.1186/s40834-016-0021-6. eCollection 2016.

23.

What Is New in Long-Acting Reversible Contraception?: Best Articles From the Past Year.

Stuart GS.

Obstet Gynecol. 2016 Jun;127(6):1166-7. doi: 10.1097/AOG.0000000000001462.

PMID:
27159766
24.

Intrauterine Device Placement During Cesarean Delivery and Continued Use 6 Months Postpartum: A Randomized Controlled Trial.

Levi EE, Stuart GS, Zerden ML, Garrett JM, Bryant AG.

Obstet Gynecol. 2015 Jul;126(1):5-11. doi: 10.1097/AOG.0000000000000882.

25.

Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period.

Zerden ML, Tang JH, Stuart GS, Norton DR, Verbiest SB, Brody S.

Womens Health Issues. 2015 Nov-Dec;25(6):616-21. doi: 10.1016/j.whi.2015.06.004. Epub 2015 Jul 23.

PMID:
26212318
26.

Evaluation of service quality in family planning clinics in Lusaka, Zambia.

Hancock NL, Vwalika B, Sitali ES, Mbwili-Muleya C, Chi BH, Stuart GS.

Contraception. 2015 Oct;92(4):345-9. doi: 10.1016/j.contraception.2015.06.025. Epub 2015 Jul 2.

27.

Pregnancy prevention and condom use practices among HIV-infected women on antiretroviral therapy seeking family planning in Lilongwe, Malawi.

Haddad LB, Feldacker C, Jamieson DJ, Tweya H, Cwiak C, Chaweza T, Mlundira L, Chiwoko J, Samala B, Kachale F, Bryant AG, Hosseinipour MC, Stuart GS, Hoffman I, Phiri S.

PLoS One. 2015 Mar 26;10(3):e0121039. doi: 10.1371/journal.pone.0121039. eCollection 2015.

28.

A randomized trial of levonorgestrel intrauterine system insertion 6 to 48 h compared to 6 weeks after vaginal delivery; lessons learned.

Stuart GS, Lesko CR, Stuebe AM, Bryant AG, Levi EE, Danvers AI.

Contraception. 2015 Apr;91(4):284-8. doi: 10.1016/j.contraception.2014.12.009. Epub 2014 Dec 29.

PMID:
25553871
29.

Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women.

O'Shea MS, Rosenberg NE, Hosseinipour MC, Stuart GS, Miller WC, Kaliti SM, Mwale M, Bonongwe PP, Tang JH.

AIDS Care. 2015;27(4):489-98. doi: 10.1080/09540121.2014.972323. Epub 2014 Nov 4.

30.

Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi.

Haddad LB, Feldacker C, Jamieson DJ, Tweya H, Cwiak C, Bryant AG, Hosseinipour MC, Chaweza T, Mlundira L, Kachale F, Stuart GS, Hoffman I, Phiri S.

Int J Gynaecol Obstet. 2014 Sep;126(3):213-6. doi: 10.1016/j.ijgo.2014.03.026. Epub 2014 May 13.

31.

Orf virus IL-10 accelerates wound healing while limiting inflammation and scarring.

Wise LM, Stuart GS, Real NC, Fleming SB, Mercer AA.

Wound Repair Regen. 2014 May-Jun;22(3):356-67. doi: 10.1111/wrr.12169.

PMID:
24844335
32.

Effect of an educational script on postpartum contraceptive use: a randomized controlled trial.

Tang JH, Dominik RC, Zerden ML, Verbiest SB, Brody SC, Stuart GS.

Contraception. 2014 Aug;90(2):162-7. doi: 10.1016/j.contraception.2014.03.017. Epub 2014 Apr 12.

PMID:
24833047
33.

Lawsuits against Mirena®: potential impact on public health.

Danvers AA, Stuart GS, Bryant AG.

Contraception. 2014 Jun;89(6):489-92. doi: 10.1016/j.contraception.2014.03.013. Epub 2014 Mar 27. No abstract available.

PMID:
24768305
34.

Hormonal contraception and HIV: the methods have confused the message.

Schwartz SR, Pettifor A, Stuart GS, Cohen MS.

AIDS. 2013 Oct;27 Suppl 1:S45-53. doi: 10.1097/QAD.0000000000000037.

PMID:
24088683
35.

Immediate postpartum versus 6-week postpartum intrauterine device insertion: a feasibility study of a randomized controlled trial.

Bryant AG, Kamanga G, Stuart GS, Haddad LB, Meguid T, Mhango C.

Afr J Reprod Health. 2013 Jun;17(2):72-9.

PMID:
24069753
36.

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate.

Haddad LB, Cwiak C, Jamieson DJ, Feldacker C, Tweya H, Hosseinipour M, Hoffman I, Bryant AG, Stuart GS, Noah I, Mulundila L, Samala B, Mayne P, Phiri S.

Contraception. 2013 Dec;88(6):737-43. doi: 10.1016/j.contraception.2013.08.006. Epub 2013 Aug 23.

37.

Family planning intentions: a qualitative exploration of postpartum women of Mexican descent in North Carolina.

Zerden ML, Stuart GS, Verbiest S, deRosset L, Tang J.

Contraception. 2013 Nov;88(5):624-8. doi: 10.1016/j.contraception.2013.05.008. Epub 2013 May 22.

PMID:
23790435
38.

Characteristics associated with interest in long-acting reversible contraception in a postpartum population.

Tang JH, Dominik R, Re S, Brody S, Stuart GS.

Contraception. 2013 Jul;88(1):52-7. doi: 10.1016/j.contraception.2012.10.014. Epub 2012 Nov 15.

PMID:
23158805
39.

Screening women for oral contraception: can family history identify inherited thrombophilias?

Grimes DA, Stuart GS, Levi EE.

Obstet Gynecol. 2012 Oct;120(4):889-95. Review.

PMID:
22996107
40.

Long-acting reversible contraceptive methods for adolescents with chronic medical problems.

Bryant AG, Stuart GS, Narasimhan S.

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):347-51. doi: 10.1016/j.jpag.2012.05.016. Epub 2012 Aug 25. Review.

PMID:
22929761
41.

The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration.

Wise LM, Inder MK, Real NC, Stuart GS, Fleming SB, Mercer AA.

Cell Microbiol. 2012 Sep;14(9):1376-90. doi: 10.1111/j.1462-5822.2012.01802.x. Epub 2012 May 15.

PMID:
22507661
42.

Feticidal digoxin injection before dilation and evacuation abortion: evidence and ethics.

Grimes DA, Stuart GS, Raymond EG.

Contraception. 2012 Feb;85(2):140-3. doi: 10.1016/j.contraception.2011.04.001. Epub 2011 May 26. No abstract available.

PMID:
22067810
43.

Feasibility of postpartum placement of the levonorgestrel intrauterine system more than 6 h after vaginal birth.

Stuart GS, Bryant AG, O'Neill E, Doherty IA.

Contraception. 2012 Apr;85(4):359-62. doi: 10.1016/j.contraception.2011.08.005. Epub 2011 Sep 28.

44.

Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi.

Stuart GS, Moses A, Corbett A, Phiri G, Kumwenda W, Mkandawire N, Chintedze J, Malunga G, Hosseinipour M, Cohen MS, Stanczyk FZ, Kashuba AD.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e40-3. doi: 10.1097/QAI.0b013e31822b8bf8. No abstract available.

45.

Couples, sexual networks, populations: implications for use of coitus interruptus.

Doherty IA, Stuart GS.

Sex Transm Dis. 2011 Jul;38(7):675. doi: 10.1097/OLQ.0b013e31821fffd8. No abstract available.

PMID:
21844716
46.

Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation.

Bryant AG, Grimes DA, Garrett JM, Stuart GS.

Obstet Gynecol. 2011 Apr;117(4):788-92. doi: 10.1097/AOG.0b013e31820c3d26.

PMID:
21422848
47.

Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in sub-Saharan Africa.

Stuart GS.

Contraception. 2009 Nov;80(5):412-6. doi: 10.1016/j.contraception.2009.03.014. Epub 2009 May 9.

PMID:
19835713
48.

Coitus interruptus is not contraception.

Doherty IA, Stuart GS.

Sex Transm Dis. 2011 Apr;38(4):356. doi: 10.1097/OLQ.0b013e3181bc0628. No abstract available.

PMID:
19801963
49.

Social desirability bias in family planning studies: a neglected problem.

Stuart GS, Grimes DA.

Contraception. 2009 Aug;80(2):108-12. doi: 10.1016/j.contraception.2009.02.009. Epub 2009 Apr 22.

PMID:
19631784
50.

HIV transmission by HIV-infected women using hormonal contraception.

Stuart GS.

Clin Infect Dis. 2009 Feb 15;48(4):499-500. doi: 10.1086/596551. No abstract available.

Supplemental Content

Loading ...
Support Center